Mr. John Howard Lavalette, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 31 Sycamore Rd, Glastonbury, CT 06033 Phone: 860-721-7561 Fax: 860-721-9199 |
Manuel A. Orta Cobo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 55 Nye Rd Ste 105, Glastonbury, CT 06033 Phone: 860-375-5088 Fax: 860-590-2030 |
Dr. Sharon K Pool, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 379 Naubuc Ave, Glastonbury, CT 06033 Phone: 860-652-3325 Fax: 860-652-0445 |
Dr. Gubbanna V Kumar, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 131 New London Tpke Ste 322, Glastonbury, CT 06033 Phone: 860-781-8181 |
Robert S. Adamenko, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 320 Western Blvd, Suite 102, Glastonbury, CT 06033 Phone: 860-633-9235 |
Julie Macneil, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 290 Western Blvd, Glastonbury, CT 06033 Phone: 888-344-0007 Fax: 860-652-9277 |
Dr. Joy E Hong, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 379 Naubuc Ave, Glastonbury, CT 06033 Phone: 860-652-3325 Fax: 860-652-0445 |
Dr. Steven L Craig, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 290 Western Blvd, Glastonbury, CT 06033 Phone: 860-652-3325 Fax: 860-652-0445 |
Dr. Jessica Weyman Tutolo, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 290 Western Blvd, Glastonbury, CT 06033 Phone: 860-652-3325 Fax: 860-652-0445 |
Dr. Kenneth R Inchalik, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2130 Main St, Glastonbury, CT 06033 Phone: 860-659-4414 Fax: 860-659-3320 |
Dr. Cecille Freilich, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 379 Naubuc Ave, Glastonbury, CT 06033 Phone: 860-652-3325 Fax: 860-652-0445 |
News Archive
Everyone knows that high doses of radiation are dangerous, but the effects of long-term exposure to low-level radiation is poorly understood. RISC-RAD, a new European Union backed research project, seeks to identify our tolerance threshold so as to optimise protective measures.
1260 people from across Finland, aged 60–77 years, were included in the study, with half randomly allocated to the intervention group, and half allocated to a control group, who received regular health advice only. All of the study participants were deemed to be at risk of dementia, based on standardised test scores.
Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.
Researchers at the German Center for Neurodegenerative Diseases and the Institute for Stroke and Dementia Research at the University Hospital of the Ludwig-Maximilians-Universität in Munich have found that a protein called TREM2 could positively influence the course of Alzheimer's disease.
› Verified 3 days ago